Victorian Health Minister officially opens Johnson & Johnson Innovation Partnering Office at Monash University
The new Johnson & Johnson Innovation Partnering Office at Monash (JJIPO@MONASH) was officially opened today by the Victorian Health Minister, the Hon. Jill Hennessy MP at Monash University in Clayton.
The office will serve as Johnson & Johnson Innovation’s local base to identify and nurture state-wide pharmaceutical and med-tech projects that can be partnered towards commercialisation.
JJIPO@MONASH will facilitate access by Victorian researchers and companies to the global expertise in scientist research, investment, and commercialisation of the Johnson & Johnson Family of Companies across pharmaceuticals, medical devices and consumer.
Minister Hennessy MP said the new office is a great example of how Victoria’s leading research institutes and universities are partnering with major global players to drive growth in the medtech and pharma sector.
“We’re proud to have so many leading researchers here in Victoria. The new Johnson & Johnson Innovation Partnering Office at Monash will give our world-class researchers the support they need to transform their findings into everyday care for Victorians while also supporting local jobs.”
The opening ceremony was attended by leaders from industry, government, and academia, including the Hon. Jill Hennessy MP, Victorian Minister for Health; Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals at Johnson & Johnson; and Sarah Newton, Pro Vice-Chancellor of Monash University (Enterprise).
JJIPO@Monash is the second partnering office that Johnson & Johnson Innovation has opened in Australia, following the success of the first Johnson & Johnson Innovation Partnering Office in Queensland (JJIPO@QUT), which was announced in 2016 in partnership with the Queensland Government and Queensland University of Technology.
Monash President and Vice-Chancellor Professor Margaret Gardner AO said the office demonstrated the University’s commitment to supporting new partnerships in biomedical innovation.
“Monash University has established a world class reputation for helping to solve some of the most pressing challenges of our time. The new Johnson & Johnson Innovation Partnering Office, which expands on our existing partnership with the Johnson & Johnson Family of Companies, greatly advances Victoria’s expertise in biomedical research, fostering new partnerships and innovation to create real and lasting impact worldwide,” Professor Gardner said.
Australia ranks 5th in the world for life science innovation (*) and Victoria is home to over 40% of Australia’s ASX listed health science companies. According to Sarah Newton, Pro Vice-Chancellor of Monash University (Enterprise), positioning the JJIPO@MONASH makes sense.
“Placing the office at Monash University ensures that the expertise of Johnson & Johnson Innovation is linked to universities, research centres, and industries across the state of Victoria, as well as nationally and globally, ultimately facilitating collaborations that can fast track healthcare innovations to the patients that need them,” she said.
The Victorian Government has identified medical technologies and pharmaceuticals as one of eight priority sectors with strong potential for significant growth. The sector already employs 23,000 people in industry across the state, generating $12.7 billion in revenue.
*Scientific American Worldview, 2016